Erratum

Erratum for the Research Article: “PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer” by A. Bosch, Z. Li, A. Bergamaschi, H. Ellis, E. Toska, A. Prat, J. J. Tao, D. E. Spratt, N. T. Viola-Villegas, P. Castel, G. Minuesa, N. Morse, J. Rodón, Y. Ibrahim, J. Cortes, J. Perez-Garcia, P. Galvan, J. Grueso, M. Guzman, J. A. Katzenellenbogen, M. Kharas, J. S. Lewis, M. Dickler, V. Serra, N. Rosen, S. Chandarlapaty, M. Scaltriti, J. Baselga

See allHide authors and affiliations

Science Translational Medicine  24 Oct 2018:
Vol. 10, Issue 464, eaav7516
DOI: 10.1126/scitranslmed.aav7516

In the Research Article “PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer,” the authors have provided additional competing interests upon request by the editors, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

Navigate This Article